Biography

Tom Scriba is professor in immunology at the South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town. He leads the Immunology Laboratory at SATVI and has research interests in the development of biomarkers, correlates of risk of TB and immune correlates of protection against TB, as well as development of novel TB vaccines.

Expertise

TB Diagnostics
Public Health

Key Impacts

Immunological signatures of asymptomatic TB

Impact details available upon request.

Source: Conference 2024
Correlates of risk of TB disease following H56 administration to prevent disease recurrence 

Impact details available upon request.

Source: Conference 2024

Research Summaries